|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.80/2.24
|
企業價值
1.56B
|
資產負債 |
每股賬面淨值
10.68
|
現金流量 |
現金流量率
0.13
|
損益表 |
收益
310.46M
|
每股收益
4.64
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/23 22:23 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. |